9 results
P.060 Provider and patient perspectives on outcome measure use in clinical care for chronic inflammatory neuropathy
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 51 / Issue s1 / June 2024
- Published online by Cambridge University Press:
- 24 May 2024, p. S32
-
- Article
-
- You have access
- Export citation
P.014 Intravenous immunoglobulin use for central nervous system disorders in British Columbia: implementation of a provincial screening program
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 51 / Issue s1 / June 2024
- Published online by Cambridge University Press:
- 24 May 2024, p. S18
-
- Article
-
- You have access
- Export citation
P.029 Relevance and home completion rate of patient reported outcome measures set in chronic inflammatory neuropathies
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 50 / Issue s2 / June 2023
- Published online by Cambridge University Press:
- 05 June 2023, p. S65
-
- Article
-
- You have access
- Export citation
P.108 Use of intravenous immunoglobulin for central nervous system disorders in British Columbia: consensus guidelines
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 49 / Issue s1 / June 2022
- Published online by Cambridge University Press:
- 24 June 2022, pp. S36-S37
-
- Article
-
- You have access
- Export citation
P.040 Value-based approach to the management of Inflammatory Neuropathies: Incorporating objective outcome measures in clinical care
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 49 / Issue s1 / June 2022
- Published online by Cambridge University Press:
- 24 June 2022, p. S18
-
- Article
-
- You have access
- Export citation
P.048 Objective measures of balance deficits in sensory ganglionopathy
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 49 / Issue s1 / June 2022
- Published online by Cambridge University Press:
- 24 June 2022, p. S20
-
- Article
-
- You have access
- Export citation
P.056 Optimizing IVIg Use for Neuromuscular Conditions in British Columbia, Canada – Targeting High and Chronic User Groups
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 48 / Issue s3 / November 2021
- Published online by Cambridge University Press:
- 05 January 2022, p. S35
-
- Article
-
- You have access
- Export citation
P.091 Consensus Guidelines for Utilization and Monitoring of Intravenous Immunoglobulin for Central Nervous System Disorders in British Columbia
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 48 / Issue s3 / November 2021
- Published online by Cambridge University Press:
- 05 January 2022, p. S45
-
- Article
-
- You have access
- Export citation
P.060 Immunoglobulin Use For Neuromuscular Conditions: Updating British Columbia Provincial Guidelines Through Focused Literature Review
-
- Journal:
- Canadian Journal of Neurological Sciences / Volume 48 / Issue s3 / November 2021
- Published online by Cambridge University Press:
- 05 January 2022, pp. S35-S36
-
- Article
-
- You have access
- Export citation